BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS).

Trial Profile

BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS).

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2009

At a glance

  • Drugs Olanzapine; Olanzapine
  • Indications Bipolar disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Acronyms PLATYPUS
  • Sponsors Eli Lilly
  • Most Recent Events

    • 28 Sep 2008 Actual number of patients enrolled was 151 according to the ClinicalTrials.gov record.
    • 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 19 Nov 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top